173 related articles for article (PubMed ID: 34281161)
1. Overlap Arrhythmia Syndromes Resulting from Multiple Genetic Variations Studied in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
Treat JA; Pfeiffer R; Barajas-Martinez H; Goodrow RJ; Bot C; Haedo RJ; Knox R; Cordeiro JM
Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281161
[TBL] [Abstract][Full Text] [Related]
2. Biophysical comparison of sodium currents in native cardiac myocytes and human induced pluripotent stem cell-derived cardiomyocytes.
Goodrow RJ; Desai S; Treat JA; Panama BK; Desai M; Nesterenko VV; Cordeiro JM
J Pharmacol Toxicol Methods; 2018; 90():19-30. PubMed ID: 29128504
[TBL] [Abstract][Full Text] [Related]
3. Switch From Fetal to Adult
Veerman CC; Mengarelli I; Lodder EM; Kosmidis G; Bellin M; Zhang M; Dittmann S; Guan K; Wilde AAM; Schulze-Bahr E; Greber B; Bezzina CR; Verkerk AO
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28739862
[TBL] [Abstract][Full Text] [Related]
4. Electrophysiological mechanisms of vandetanib-induced cardiotoxicity: Comparison of action potentials in rabbit Purkinje fibers and pluripotent stem cell-derived cardiomyocytes.
Lee HA; Hyun SA; Byun B; Chae JH; Kim KS
PLoS One; 2018; 13(4):e0195577. PubMed ID: 29630634
[TBL] [Abstract][Full Text] [Related]
5. Anti-arrhythmic potential of the late sodium current inhibitor GS-458967 in murine Scn5a-1798insD+/- and human SCN5A-1795insD+/- iPSC-derived cardiomyocytes.
Portero V; Casini S; Hoekstra M; Verkerk AO; Mengarelli I; Belardinelli L; Rajamani S; Wilde AAM; Bezzina CR; Veldkamp MW; Remme CA
Cardiovasc Res; 2017 Jun; 113(7):829-838. PubMed ID: 28430892
[TBL] [Abstract][Full Text] [Related]
6. Maturation of hiPSC-derived cardiomyocytes promotes adult alternative splicing of SCN5A and reveals changes in sodium current associated with cardiac arrhythmia.
Campostrini G; Kosmidis G; Ward-van Oostwaard D; Davis RP; Yiangou L; Ottaviani D; Veerman CC; Mei H; Orlova VV; Wilde AAM; Bezzina CR; Verkerk AO; Mummery CL; Bellin M
Cardiovasc Res; 2023 Mar; 119(1):167-182. PubMed ID: 35394010
[TBL] [Abstract][Full Text] [Related]
7. Modeling Reentry in the Short QT Syndrome With Human-Induced Pluripotent Stem Cell-Derived Cardiac Cell Sheets.
Shinnawi R; Shaheen N; Huber I; Shiti A; Arbel G; Gepstein A; Ballan N; Setter N; Tijsen AJ; Borggrefe M; Gepstein L
J Am Coll Cardiol; 2019 May; 73(18):2310-2324. PubMed ID: 31072576
[TBL] [Abstract][Full Text] [Related]
8. Tbx5 variants disrupt Nav1.5 function differently in patients diagnosed with Brugada or Long QT Syndrome.
Nieto-Marín P; Tinaquero D; Utrilla RG; Cebrián J; González-Guerra A; Crespo-García T; Cámara-Checa A; Rubio-Alarcón M; Dago M; Alfayate S; Filgueiras-Rama D; Peinado R; López-Sendón JL; Jalife J; Tamargo J; Bernal JA; Caballero R; Delpón E;
Cardiovasc Res; 2022 Mar; 118(4):1046-1060. PubMed ID: 33576403
[TBL] [Abstract][Full Text] [Related]
9. Patch-Clamp Recording from Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Improving Action Potential Characteristics through Dynamic Clamp.
Verkerk AO; Veerman CC; Zegers JG; Mengarelli I; Bezzina CR; Wilders R
Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28867785
[TBL] [Abstract][Full Text] [Related]
10. The G213D variant in Nav1.5 alters sodium current and causes an arrhythmogenic phenotype resulting in a multifocal ectopic Purkinje-related premature contraction phenotype in human-induced pluripotent stem cell-derived cardiomyocytes.
Calloe K; Geryk M; Freude K; Treat JA; Vold VA; Frederiksen HRS; Broendberg AK; Frederiksen TC; Jensen HK; Cordeiro JM
Europace; 2022 Dec; 24(12):2015-2027. PubMed ID: 35726875
[TBL] [Abstract][Full Text] [Related]
11. Large-Scale Simulation of the Phenotypical Variability Induced by Loss-of-Function Long QT Mutations in Human Induced Pluripotent Stem Cell Cardiomyocytes.
Paci M; Casini S; Bellin M; Hyttinen J; Severi S
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30428582
[TBL] [Abstract][Full Text] [Related]
12. Identification of an I
Ma D; Liu Z; Loh LJ; Zhao Y; Li G; Liew R; Islam O; Wu J; Chung YY; Teo WS; Ching CK; Tan BY; Chong D; Ho KL; Lim P; Yong RYY; Panama BK; Kaplan AD; Bett GCL; Ware J; Bezzina CR; Verkerk AO; Cook SA; Rasmusson RL; Wei H
Sci Rep; 2018 Jul; 8(1):11246. PubMed ID: 30050137
[TBL] [Abstract][Full Text] [Related]
13. A cellular model of Brugada syndrome with SCN10A variants using human-induced pluripotent stem cell-derived cardiomyocytes.
El-Battrawy I; Albers S; Cyganek L; Zhao Z; Lan H; Li X; Xu Q; Kleinsorge M; Huang M; Liao Z; Zhong R; Rudic B; Müller J; Dinkel H; Lang S; Diecke S; Zimmermann WH; Utikal J; Wieland T; Borggrefe M; Zhou X; Akin I
Europace; 2019 Sep; 21(9):1410-1421. PubMed ID: 31106349
[TBL] [Abstract][Full Text] [Related]
14. Modeling Short QT Syndrome Using Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
El-Battrawy I; Lan H; Cyganek L; Zhao Z; Li X; Buljubasic F; Lang S; Yücel G; Sattler K; Zimmermann WH; Utikal J; Wieland T; Ravens U; Borggrefe M; Zhou XB; Akin I
J Am Heart Assoc; 2018 Mar; 7(7):. PubMed ID: 29574456
[TBL] [Abstract][Full Text] [Related]
15. hiPSC-derived cardiomyocytes from Brugada Syndrome patients without identified mutations do not exhibit clear cellular electrophysiological abnormalities.
Veerman CC; Mengarelli I; Guan K; Stauske M; Barc J; Tan HL; Wilde AA; Verkerk AO; Bezzina CR
Sci Rep; 2016 Aug; 6():30967. PubMed ID: 27485484
[TBL] [Abstract][Full Text] [Related]
16. Modeling type 3 long QT syndrome with cardiomyocytes derived from patient-specific induced pluripotent stem cells.
Ma D; Wei H; Zhao Y; Lu J; Li G; Sahib NB; Tan TH; Wong KY; Shim W; Wong P; Cook SA; Liew R
Int J Cardiol; 2013 Oct; 168(6):5277-86. PubMed ID: 23998552
[TBL] [Abstract][Full Text] [Related]
17. Yohimbine Directly Induces Cardiotoxicity on Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
Gong Y; Yang L; Tang J; Zheng J; Witman N; Jakob P; Tan Y; Liu M; Chen Y; Wang H; Fu W; Wang W
Cardiovasc Toxicol; 2022 Feb; 22(2):141-151. PubMed ID: 34817810
[TBL] [Abstract][Full Text] [Related]
18. Loss of sodium current caused by a Brugada syndrome-associated variant is determined by patient-specific genetic background.
Martínez-Moreno R; Carreras D; Sarquella-Brugada G; Pérez GJ; Selga E; Scornik FS; Brugada R
Heart Rhythm; 2024 Mar; 21(3):331-339. PubMed ID: 38008367
[TBL] [Abstract][Full Text] [Related]
19. Repolarization instability and arrhythmia by IKr block in single human-induced pluripotent stem cell-derived cardiomyocytes and 2D monolayers.
Altrocchi C; de Korte T; Bernardi J; Spätjens RLHMG; Braam SR; Heijman J; Zaza A; Volders PGA
Europace; 2020 Sep; 22(9):1431-1441. PubMed ID: 32770183
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of nefazodone-induced cardiotoxicity in human induced pluripotent stem cell-derived cardiomyocytes.
Lee S; Lee HA; Choi SW; Kim SJ; Kim KS
Toxicol Appl Pharmacol; 2016 Apr; 296():42-53. PubMed ID: 26821276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
